Administration of recombinant activated factor VII (rFVIIa) in non-haemophiliac patients in the Czech Republic - Analysis of selected data from the UniSeven register;Podávání rekombinantního aktivovaného faktoru VII v České Republice u nemocných bez hemofilie - Analýza vybraných údajů z registru UniSeven

Anesteziologie a Intenzivni Medicina

Volumn 16, Issue 6, 2005, Pages 296-304

  Černý, Vladimir ^a,b,c   Blatny J ^d   Dusek L ^e   Brabec, P ^e  

^a CHARLES UNIVERSITY   (Czech Republic)

^b Léka ská Fakulta   (Czech Republic)

^c UNIVERSITY HOSPITAL HRADEC KRALOVE   (Czech Republic)

^d UNIVERSITY HOSPITAL BRNO   (Czech Republic)

^e MASARYK UNIVERSITY   (Czech Republic)

Author keywords

Haemorrhage; Recombinant activated factor VII

Indexed keywords

ALBUMIN; HYPERTENSIVE FACTOR; RECOMBINANT BLOOD CLOTTING FACTOR 7A;

ADOLESCENT; ADULT; AGED; ARTICLE; BLEEDING; BLOOD TRANSFUSION; BRAIN HEMORRHAGE; CANCER SURGERY; CHILD; COLLOID; CONTROLLED STUDY; CZECH REPUBLIC; DATA BASE; DRUG SAFETY; ERYTHROCYTE TRANSFUSION; HEART SURGERY; HEMOPHILIA; HUMAN; INJURY; MAJOR CLINICAL STUDY; ORTHOPEDIC SURGERY; PLASMA TRANSFUSION; POSTOPERATIVE COMPLICATION; PROSPECTIVE STUDY; REGISTER; SURVIVAL RATE; THROMBOEMBOLISM;

EID: 30444460109     PISSN: 12142158     EISSN: 18054412     Source Type: Journal    
DOI: None     Document Type: Article

References (14)

1. Hedner, U., Kiesel, W. Use of human factor VIIa in the treatment of two hemophilia A patients with high titer inhibitors. J. Clin. Invest., 1983, 71, p. 1836-1841.
2. Levi, M., Peters, M., Buller, H. R. Efficacy and safety of recombinant factor VIIa for treatment of severe bleeding: A systematic review. Crit. Care Med., 2005, 33, p. 883-890.
3. Aledort, L M. Recombinant factor VIIa: Is a pan-hemostatic agent? Thromb. Haemost., 2000, 83, p. 637-638.
4. Laffan, M., O'Connell, N. M., Perry, D. J., Hodgson, A. J., O'Shaugnessy, D., Smith, O. P. Analysis and results of the recombinant factor Vila extended-use registry. Blood Coagul. Fibrinolysis., 2003, 14, Suppl 1, S35-S38.
5. Martinowitz, U., Kenet, G., Segal, E. et al. Recombinant Activated factor VII for Adjunctive Hemorrhage Control in Trauma. J. Trauma, 2001, 51, p. 431-439.
6. Kenet, G., Walden, R., Eldad, A., Martinowitz, W. et al. Treatment of traumatic bleeding with recombinant factor VIIa. Lancet, 1999, 354, p. 1879.
7. Levi, M. et al. Efficacy and safety of recombinant factor VIIa for treatment of severe bleeding: A systematic review. Crit. Care Med, 2005, 33, p. 883-890.
8. Friedrich, P. W. et al. Effect of recombinant factor VII on perioperative blood loss in patients undergoing retropubic prostatectomy: a double blind placebo controlled randomized trial. Lancet, 2003, 361, p. 201-205.
9. Raobaikady, R., Redman, J., Ball, A. S. et al. Use of activated recombinant coagulation factor VII in patients undergoing reconstruction surgery for traumatic fracture of pelvis and acetabulum: a double-blind, randomized, placebo-controlled trial. B. J. Anaesth., 2005, 94, p. 586-591.
10. Odeyemi, I. A. O., Friedrich, P. W., Levi, M. Economic impact of recombinant activated factor VII in the control of bleeds associated with abdominal prostatectomy. Journal of Medical Economics, 2004, 7, p. 107-115.
11. Lodge, P. et al. Recombinant factor VIIa in partial hepatectomy: A randomized placebo-controlled, double blind clinical trial. J. Hepatol., 2003, 36, p. 177.
12. Diprose, P. et al. A pilot double blind randomized placebo controlled trial of the use of recombinant factor VII (rfVIIa) in high transfusion risk cardiac surgery. Eur. J. Anesthesiol., 2004, 21, Suppl 33, p. 9.
13. Mayer, S. A., Bun, N. C., Beggtrup, K. et al. Recombinant Activated factor VII for Acute Intracerebral Hemorrhage. N. Engl. J. Med., 2005, 352, p. 777-785.
14. The phase II clinical trial Preliminary Results: A Multicentre, Randomized, Double-blind Trial to Evaluate the Efficacy and Safety of Recombinant Factor VIIa in the Treatment of Bleeding in Severely Injured Trauma Patients (u̇daje poskytnuty laskavosti firmy NovoNordisk).